IACH News Podcasts

Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access.

Prof. Mohamad Mohty – FDA Breakthrough Therapy Designation for Elranatamab in Relapsed or Refractory Multiple Myeloma

CME Congresses .

Prof. Mohamad Mohty – FDA Breakthrough Therapy Designation for Elranatamab in Relapsed or Refractory Multiple Myeloma

Prof. Mohamed Kharfan Dabaja – Positive Results from Final Progression-Free Survival Analysis of zanubrutinib Compared to ibrutinib in CLL

CME Congresses .

Prof. Mohamed Kharfan Dabaja – Positive Results from Final Progression-Free Survival Analysis of zanubrutinib Compared to ibrutinib in CLL

Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL

CME Congresses .

Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL

Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes

CME Congresses .

Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes

Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia

CME Congresses .

Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia

Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers

CME Congresses .

Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers

Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis

CME Congresses .

Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis

Prof. Paul Richardson – Melflufen for the treatement of relapsed-refractory myeloma

CME Congresses .

Prof. Paul Richardson – Melflufen for the treatement of relapsed-refractory myeloma

Prof. Mohamad Mohty – New treatments for refractrory acute GVHD

CME Congresses .

Prof. Mohamad Mohty – New treatments for refractrory acute GVHD

Dr. Eolia Brissot – Approval of maribvir for post-transplant cytomegalovirus infection

CME Congresses .

Dr. Eolia Brissot – Approval of maribvir for post-transplant cytomegalovirus infection